Exhibit 107
Calculation of Filing Fee Tables
Form S-1
(Form Type)
Ayala Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward | Amount Registered | Proposed Maximum Offering Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration | |||||||||
Newly Registered Securities | ||||||||||||||||
Fees to Be Paid | Equity | Common Stock, $0.01 par value per share | 457(o) | — | — | $15,000,000.00(1) | 0.0000927 | $1,390.50 | ||||||||
Fees to Be Paid | Other | Warrants to purchase shares of Common Stock(3) | Other | — | — | —(3) | — | —(3) | ||||||||
Fees to Be Paid | Equity | Common Stock, $0.01 par value per share, issuable upon exercise of the Warrants(2) | 457(o) | — | — | $15,000,000.00(1) | 0.0000927 | $1,390.50 | ||||||||
Fees Previously Paid | — | — | — | — | — | — | — | — | ||||||||
Total Offering Amounts | $30,000,000.00 | $2,781.00 | ||||||||||||||
Total Fees Previously Paid | — | |||||||||||||||
Total Fee Offsets | — | |||||||||||||||
Net Fee Due | $2,781.00 |
(1) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”). |
(2) | Pursuant to Rule 416(a) under the Securities Act, this registration statement shall also cover an indeterminate number of shares that may be issued and resold resulting from stock splits, stock dividends or similar transactions. |
(3) | No separate registration fee required pursuant to Rule 457(g) of the Securities Act. |